ImmunoPrecise Antibodies ... (IPA)
| Bid | 0.44 |
| Market Cap | 19.91M |
| Revenue (ttm) | 24M |
| Net Income (ttm) | -46.12M |
| EPS (ttm) | -1.21 |
| PE Ratio (ttm) | -0.36 |
| Forward PE | -3.26 |
| Analyst | Buy |
| Ask | 0.45 |
| Volume | 302,876 |
| Avg. Volume (20D) | 7,706,054 |
| Open | 0.46 |
| Previous Close | 0.46 |
| Day's Range | 0.43 - 0.48 |
| 52-Week Range | 0.27 - 1.39 |
| Beta | 0.38 |
About IPA
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services incl...
Analyst Forecast
According to 2 analyst ratings, the average rating for IPA stock is "Buy." The 12-month stock price forecast is $4, which is an increase of 819.33% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago · seekingalpha.com
ImmunoPrecise Antibodies Ltd. (IPA) Q3 2025 Earnings Call TranscriptImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q3 2025 Earnings Conference Call March 28, 2025 10:30 AM ET Company Participants Jennifer Bath - Chief Executive Officer and President Joseph Scheffler - In...
